Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-11-20–present
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Recursion Pharmaceuticals, Inc. (RXRX) | Chief Financial Officer | $538,680 | $1,328,483 |
| 2024 | Recursion Pharmaceuticals, Inc. (RXRX) | Chief Financial Officer | $53,392 | $8,171,651 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.